Efficacy, Safety and Tolerability Study of Meloxicam Injection in Subjects After Abdominal Surgery
A Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Analgesic Efficacy, Safety and Tolerability of Meloxicam Injection in Subjects After Abdominal Surgery
Sponsor: Beijing Tide Pharmaceutical Co., Ltd
This PHASE2 trial investigates Pain, Post-operative and is currently ongoing. Beijing Tide Pharmaceutical Co., Ltd leads this study, which shows 4 recorded versions since 2023 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
4 versions recorded-
Aug 2025 — Present [monthly]
Unknown PHASE2
Status: Not Yet Recruiting → Unknown
-
Sep 2024 — Aug 2025 [monthly]
Not Yet Recruiting PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Not Yet Recruiting PHASE2
-
Aug 2023 — Jul 2024 [monthly]
Not Yet Recruiting PHASE2
First recorded
Jul 2023
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Beijing Tide Pharmaceutical Co., Ltd
- The Third Xiangya Hospital of Central South University
For direct contact, visit the study record on ClinicalTrials.gov .